The antihypertensive profile of the angiotensin AT1 receptor antagonist, GR138950, and the influence of potential homeostatic compensatory mechanisms in renal hypertensive rats

British Journal of Pharmacology
I K Anderson, G M Drew

Abstract

The cardiovascular profile of the angiotensin AT1 receptor antagonist, GR138950, and the influence of potential compensatory homeostatic mechanisms on this profile, were investigated in renal artery ligated hypertensive (RALH) rats. GR138950 caused a marked reduction in blood pressure associated with immediate tachycardia in conscious RALH rats. The antihypertensive action of GR138950 appeared biphasic; an immediate fall in blood pressure, which plateaued within 1 h, and which was followed by a further slow decline that reached maximum between 5-7 h after administration. The tachycardia caused by GR138950 was attenuated by atenolol and was abolished by combined pretreatment with atenolol and atropine methyl nitrate. However, the antihypertensive profile of GR138950 was unchanged by these pretreatments. The resting blood pressure and the antihypertensive effect of GR138950, in RALH rats, were unaffected by the vasopressin V1 receptor antagonist, [beta-mercapto-beta,beta-cyclopentamethylene propionyl(1)-O-Me-Tyr2,Arg8]-vasopressin. Thus, vasopressinergic mechanisms are not involved in either maintaining blood pressure in RALH rats, or in compensating for the fall in blood pressure caused by GR138950. In anaesthetized RALH rats, G...Continue Reading

References

Jan 1, 1979·General Pharmacology·R E Buckingham, T C Hamilton
Dec 1, 1992·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·M A SchalekampA H van den Meiracker
Jan 1, 1992·Journal of Cardiovascular Pharmacology·U SteckelingsT Unger
Jun 11, 1992·Naunyn-Schmiedeberg's Archives of Pharmacology·D P BrooksM Gellai
Jan 1, 1990·Journal of Cardiovascular Pharmacology·D L Barringer, R D Buñag
Aug 1, 1990·British Journal of Pharmacology·R G BogleA G Ramage
Jan 1, 1986·Journal of Cardiovascular Pharmacology·M Manning, W H Sawyer
Jan 1, 1988·Circulation·R Shabetai
Apr 1, 1987·Hypertension·G D FinkM L Mangiapane
Feb 1, 1985·Cardiovascular Research·T Bennett, S M Gardiner
Jan 1, 1982·Journal of Cardiovascular Pharmacology·R Hatton, D P Clough
Jul 4, 1995·European Journal of Pharmacology·K L ClarkG M Drew
Jul 1, 1993·Journal of Cardiovascular Pharmacology·N MoreauJ F Giudicelli
Jan 1, 1994·British Journal of Pharmacology·A HilditchM J Robertson
May 1, 1993·Current Problems in Diagnostic Radiology·A M DelBalso, R E Hall
Jan 1, 1997·European Journal of Clinical Pharmacology·M BindschedlerG Preiswerk

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.